[go: up one dir, main page]

WO2008046606A3 - Composition topique pour le traitement d'eczéma - Google Patents

Composition topique pour le traitement d'eczéma Download PDF

Info

Publication number
WO2008046606A3
WO2008046606A3 PCT/EP2007/009004 EP2007009004W WO2008046606A3 WO 2008046606 A3 WO2008046606 A3 WO 2008046606A3 EP 2007009004 W EP2007009004 W EP 2007009004W WO 2008046606 A3 WO2008046606 A3 WO 2008046606A3
Authority
WO
WIPO (PCT)
Prior art keywords
eczema
treatment
topical composition
neurodermitis
infants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2007/009004
Other languages
German (de)
English (en)
Other versions
WO2008046606A2 (fr
Inventor
Michael Rochel
Uwe-Bernd Rose
Roman Christian Rochel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2008046606A2 publication Critical patent/WO2008046606A2/fr
Publication of WO2008046606A3 publication Critical patent/WO2008046606A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des compositions topiques non grasses dans une formulation appropriée pour l'application sur la peau, à base d'eau et avec de l'acide hyaluronique et/ou son sel et au moins un sel électrolytique comme composants, et éventuellement du sulfate de chondroïtine, dans une composition ressemblant au liquide amniotique. Elle est particulièrement appropriée pour le traitement et la prévention d'eczémas et notamment des neurodermites, de l'eczéma atopique et de l'eczéma du nourrisson.
PCT/EP2007/009004 2006-10-20 2007-10-17 Composition topique pour le traitement d'eczéma Ceased WO2008046606A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006049580.2 2006-10-20
DE102006049580A DE102006049580A1 (de) 2006-10-20 2006-10-20 Topische Zusammensetzung zur Behandlung von Ekzemen

Publications (2)

Publication Number Publication Date
WO2008046606A2 WO2008046606A2 (fr) 2008-04-24
WO2008046606A3 true WO2008046606A3 (fr) 2008-06-19

Family

ID=39185708

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/009004 Ceased WO2008046606A2 (fr) 2006-10-20 2007-10-17 Composition topique pour le traitement d'eczéma

Country Status (2)

Country Link
DE (1) DE102006049580A1 (fr)
WO (1) WO2008046606A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20120554A1 (it) * 2012-06-22 2012-09-21 Martini Francesco De Composizione per l'idratazione e la depurazione della cute.
CN106902286B (zh) * 2017-03-07 2021-01-29 上海中医药大学附属曙光医院 一种治疗婴幼儿湿疹的中药组合物、其制备方法及应用
US12337056B2 (en) 2018-05-29 2025-06-24 Mary Kay Inc. Topical compositions and methods
EP4580751A2 (fr) 2022-09-29 2025-07-09 Adora Animal Health Corporation Formulations pénétrant dans la peau de glycosaminoglycanes sulfatés et fragments dérivés de celles-ci pour le traitement de la douleur et d'autres états médicaux

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0136782A2 (fr) * 1983-08-09 1985-04-10 Nestle S.A. Compositions de sulfate de chondroitine/hyaluronate de sodium
EP0715852A1 (fr) * 1994-12-05 1996-06-12 Denki Kagaku Kogyo Kabushiki Kaisha Utilisation de l'acide hyaluronique ou son sel pour le traitement des désordres de la peau
US5631242A (en) * 1993-08-04 1997-05-20 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions utilized for treatment of diseases of cutis
US20010009908A1 (en) * 1996-04-04 2001-07-26 Diego Ponzin Corneal storage fluid comprised of hyaluronic acid
US20020132790A1 (en) * 1993-07-30 2002-09-19 Luca Benedetti Pharmaceutical compositions for topical use containing hyaluronic acid and its derivatives
US20020168412A1 (en) * 1995-09-29 2002-11-14 L.A.M. Pharmaceutical Corp. Topical drug preparations
US20030021834A1 (en) * 1996-08-07 2003-01-30 Petito George D. Method for use of hyaluronic acid in wound management
US20040136925A1 (en) * 2002-08-30 2004-07-15 Giuseppe Petrigni Pharmaceutical preparation in colloidal form, useful in the treatment of skin diseases
US20050147679A1 (en) * 1998-03-24 2005-07-07 Petito George D. Composition and method for healing tissues
WO2005110439A2 (fr) * 2004-05-07 2005-11-24 S.K. Pharmaceuticals, Inc. Préparations de hyaluronane stabilisé et méthodes correspondantes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003529590A (ja) * 2000-03-21 2003-10-07 アスション デヴェロップメント エーピーエス ピリジンカルボキシ誘導体およびｈ２ヒスタミン受容体アンタゴニストからなる化学的複合体
DE10230026A1 (de) * 2002-07-04 2004-01-22 Beiersdorf Ag Kosmetische Zubereitung zur Behandlung trockener oder empfindlicher Haut
JPWO2004016236A1 (ja) * 2002-08-14 2005-12-02 株式会社ファンケル 化粧料
DE10238161A1 (de) * 2002-08-15 2004-02-26 Köhler Pharma GmbH Mineralstoff-Ampulle für die mucosale und topische Wirkstoffapplikation
DE102004002001A1 (de) * 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen
WO2007099398A2 (fr) * 2005-09-27 2007-09-07 Naturalite Benelux B.V. procédés et compositions pour le traitement de la peau
ITMI20060742A1 (it) * 2006-04-13 2007-10-14 Patrizia Pattini Composizioni antibatteriche per il trattamento di infezioni delle alte e basse via aeree

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0136782A2 (fr) * 1983-08-09 1985-04-10 Nestle S.A. Compositions de sulfate de chondroitine/hyaluronate de sodium
US20020132790A1 (en) * 1993-07-30 2002-09-19 Luca Benedetti Pharmaceutical compositions for topical use containing hyaluronic acid and its derivatives
US5631242A (en) * 1993-08-04 1997-05-20 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions utilized for treatment of diseases of cutis
EP0715852A1 (fr) * 1994-12-05 1996-06-12 Denki Kagaku Kogyo Kabushiki Kaisha Utilisation de l'acide hyaluronique ou son sel pour le traitement des désordres de la peau
US20020168412A1 (en) * 1995-09-29 2002-11-14 L.A.M. Pharmaceutical Corp. Topical drug preparations
US20010009908A1 (en) * 1996-04-04 2001-07-26 Diego Ponzin Corneal storage fluid comprised of hyaluronic acid
US20030021834A1 (en) * 1996-08-07 2003-01-30 Petito George D. Method for use of hyaluronic acid in wound management
US20050147679A1 (en) * 1998-03-24 2005-07-07 Petito George D. Composition and method for healing tissues
US20040136925A1 (en) * 2002-08-30 2004-07-15 Giuseppe Petrigni Pharmaceutical preparation in colloidal form, useful in the treatment of skin diseases
WO2005110439A2 (fr) * 2004-05-07 2005-11-24 S.K. Pharmaceuticals, Inc. Préparations de hyaluronane stabilisé et méthodes correspondantes

Also Published As

Publication number Publication date
WO2008046606A2 (fr) 2008-04-24
DE102006049580A1 (de) 2008-04-24

Similar Documents

Publication Publication Date Title
WO2006086740A3 (fr) Compositions cosmetiques et cosmeceutiques destinees a la restauration de la fonction de barriere cutanee
WO2009090617A3 (fr) Compositions nettoyantes concentrées pour soins personnels
GB2431876B (en) Use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions
WO2013098066A3 (fr) Compositions aqueuses pour le nettoyage des cheveux et de la peau, contenant des tensioactifs biologiques
WO2009155513A3 (fr) Immunoglobulines présentant une agrégation réduite
NO20072895L (no) Topiske sammensetninger inneholdende myrica gale olje
WO2011148328A3 (fr) Procédé cosmétique pour le maquillage et/ou le soin de la peau et/ou des lèvres
WO2008139122A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2009074735A8 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2007141392A3 (fr) Compositions comprenant de l'acide bétulonique
WO2014099226A3 (fr) Compositions d'hygiène personnel comprenant un halogénure d'acide aminé/triméthylglycine de zinc
NZ596254A (en) Cleanser compositions and methods for using the same comprising linalool, hinokitiol, diol and surfactant
WO2009017369A3 (fr) Compositions contenant des dérivés de dibenzo-p-dioxine permettant de protéger la peau et de soulager les maladies de peau
WO2013122861A3 (fr) Additif pour composition revitalisante permettant de procurer des bénéfices immédiats et de longue durée à des substrats de kératine
WO2009135006A3 (fr) Compositions de soin pour les cheveux visant à prévenir les dommages oxydants sur les cheveux, procédés d'utilisation et procédés de commercialisation de ces compositions
WO2008079760A3 (fr) Pigments nanocomposites dans une application cosmétique topique
WO2008037380A3 (fr) Mélanges d'alkylbenzoates
WO2011163589A3 (fr) Additif pour composition de soins personnels pour application sur substrats de kératine afin d'apporter des avantages de longue durée
WO2009024677A3 (fr) Utilisation d ' acide hyaluronique pour la preparation de compositions destinees a l' amelioration de la fonction de protection de la peau, de l' oeil et des muqueuses
WO2009077693A3 (fr) Compositions comprenant au moins un derive de l'acide naphtoique, du peroxyde de benzoyle et au moins un agent filmogene
WO2012052536A3 (fr) Composition cosmétique comprenant de l'aloe vera et un dérivé d'acide iséthionique
EP2275104A3 (fr) Composition pharmaceutique et cosmétique comprenant de la lactoferrine, du ciclopirox et de l'acide étidronique
WO2008082736A3 (fr) Compositions et leurs procédés d'utilisation pour améliorer la condition et l'apparence de la peau
WO2015013691A3 (fr) Formulation de produit de soin buccal
WO2012175743A3 (fr) Procédés de préparation d'une composition cosmétique à partir de fluide d'éclosion et utilisations de cette composition pour améliorer l'aspect cosmétique de la peau

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07819072

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE